nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Dactinomycin—muscle cancer	0.182	0.34	CbGbCtD
Terazosin—ABCB1—Vincristine—muscle cancer	0.112	0.21	CbGbCtD
Terazosin—ABCB1—Etoposide—muscle cancer	0.103	0.192	CbGbCtD
Terazosin—ABCB1—Doxorubicin—muscle cancer	0.0701	0.131	CbGbCtD
Terazosin—ABCB1—Methotrexate—muscle cancer	0.0679	0.127	CbGbCtD
Terazosin—Photosensitivity reaction—Vincristine—muscle cancer	0.00392	0.00842	CcSEcCtD
Terazosin—Speech disorder—Methotrexate—muscle cancer	0.00386	0.0083	CcSEcCtD
Terazosin—Pharyngitis—Dactinomycin—muscle cancer	0.00382	0.00821	CcSEcCtD
Terazosin—Depression—Vincristine—muscle cancer	0.00382	0.0082	CcSEcCtD
Terazosin—Amblyopia—Doxorubicin—muscle cancer	0.00372	0.008	CcSEcCtD
Terazosin—Sweating—Vincristine—muscle cancer	0.00367	0.00789	CcSEcCtD
Terazosin—Vasodilation—Doxorubicin—muscle cancer	0.00327	0.00703	CcSEcCtD
Terazosin—Vasodilation procedure—Doxorubicin—muscle cancer	0.00327	0.00703	CcSEcCtD
Terazosin—Arthropathy—Doxorubicin—muscle cancer	0.00316	0.0068	CcSEcCtD
Terazosin—Cough increased—Doxorubicin—muscle cancer	0.00314	0.00675	CcSEcCtD
Terazosin—Ill-defined disorder—Dactinomycin—muscle cancer	0.00311	0.00668	CcSEcCtD
Terazosin—Jaundice—Etoposide—muscle cancer	0.00302	0.0065	CcSEcCtD
Terazosin—Malaise—Dactinomycin—muscle cancer	0.00302	0.00649	CcSEcCtD
Terazosin—Coordination abnormal—Doxorubicin—muscle cancer	0.00293	0.00629	CcSEcCtD
Terazosin—Neck pain—Doxorubicin—muscle cancer	0.00291	0.00625	CcSEcCtD
Terazosin—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00291	0.00625	CcSEcCtD
Terazosin—Back pain—Vincristine—muscle cancer	0.00289	0.00622	CcSEcCtD
Terazosin—Myalgia—Dactinomycin—muscle cancer	0.00285	0.00613	CcSEcCtD
Terazosin—Abnormal dreams—Doxorubicin—muscle cancer	0.00284	0.00611	CcSEcCtD
Terazosin—Discomfort—Dactinomycin—muscle cancer	0.00282	0.00605	CcSEcCtD
Terazosin—Photosensitivity—Methotrexate—muscle cancer	0.00274	0.0059	CcSEcCtD
Terazosin—Oedema—Dactinomycin—muscle cancer	0.00273	0.00587	CcSEcCtD
Terazosin—Vertigo—Vincristine—muscle cancer	0.00269	0.00578	CcSEcCtD
Terazosin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00267	0.00575	CcSEcCtD
Terazosin—Anorexia—Dactinomycin—muscle cancer	0.0026	0.0056	CcSEcCtD
Terazosin—Eye disorder—Etoposide—muscle cancer	0.0026	0.00559	CcSEcCtD
Terazosin—Convulsion—Vincristine—muscle cancer	0.00259	0.00557	CcSEcCtD
Terazosin—Myalgia—Vincristine—muscle cancer	0.00255	0.00547	CcSEcCtD
Terazosin—Abnormal vision—Doxorubicin—muscle cancer	0.00251	0.00539	CcSEcCtD
Terazosin—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00249	0.00535	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00249	0.00535	CcSEcCtD
Terazosin—Cerebrovascular accident—Methotrexate—muscle cancer	0.00246	0.00529	CcSEcCtD
Terazosin—Anaphylactic shock—Vincristine—muscle cancer	0.00244	0.00525	CcSEcCtD
Terazosin—Oedema—Vincristine—muscle cancer	0.00244	0.00525	CcSEcCtD
Terazosin—Osteoarthritis—Methotrexate—muscle cancer	0.00241	0.00518	CcSEcCtD
Terazosin—Thrombocytopenia—Vincristine—muscle cancer	0.00239	0.00514	CcSEcCtD
Terazosin—Photosensitivity—Doxorubicin—muscle cancer	0.00238	0.00511	CcSEcCtD
Terazosin—Decreased appetite—Dactinomycin—muscle cancer	0.00237	0.00511	CcSEcCtD
Terazosin—Dysgeusia—Etoposide—muscle cancer	0.00237	0.0051	CcSEcCtD
Terazosin—Hyperhidrosis—Vincristine—muscle cancer	0.00236	0.00507	CcSEcCtD
Terazosin—Fatigue—Dactinomycin—muscle cancer	0.00236	0.00506	CcSEcCtD
Terazosin—Back pain—Etoposide—muscle cancer	0.00234	0.00504	CcSEcCtD
Terazosin—Pain—Dactinomycin—muscle cancer	0.00234	0.00502	CcSEcCtD
Terazosin—Anorexia—Vincristine—muscle cancer	0.00233	0.005	CcSEcCtD
Terazosin—Hypotension—Vincristine—muscle cancer	0.00228	0.0049	CcSEcCtD
Terazosin—Feeling abnormal—Dactinomycin—muscle cancer	0.00225	0.00484	CcSEcCtD
Terazosin—Ill-defined disorder—Etoposide—muscle cancer	0.00225	0.00483	CcSEcCtD
Terazosin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00223	0.0048	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00222	0.00478	CcSEcCtD
Terazosin—Insomnia—Vincristine—muscle cancer	0.00221	0.00475	CcSEcCtD
Terazosin—Paraesthesia—Vincristine—muscle cancer	0.00219	0.00471	CcSEcCtD
Terazosin—Malaise—Etoposide—muscle cancer	0.00218	0.0047	CcSEcCtD
Terazosin—Vertigo—Etoposide—muscle cancer	0.00218	0.00468	CcSEcCtD
Terazosin—Body temperature increased—Dactinomycin—muscle cancer	0.00216	0.00464	CcSEcCtD
Terazosin—Abdominal pain—Dactinomycin—muscle cancer	0.00216	0.00464	CcSEcCtD
Terazosin—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00216	0.00463	CcSEcCtD
Terazosin—Cardiac failure—Doxorubicin—muscle cancer	0.00214	0.0046	CcSEcCtD
Terazosin—Loss of consciousness—Etoposide—muscle cancer	0.00213	0.00458	CcSEcCtD
Terazosin—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00213	0.00458	CcSEcCtD
Terazosin—Decreased appetite—Vincristine—muscle cancer	0.00212	0.00456	CcSEcCtD
Terazosin—Cough—Etoposide—muscle cancer	0.00211	0.00455	CcSEcCtD
Terazosin—Fatigue—Vincristine—muscle cancer	0.0021	0.00452	CcSEcCtD
Terazosin—Convulsion—Etoposide—muscle cancer	0.0021	0.00451	CcSEcCtD
Terazosin—Pain—Vincristine—muscle cancer	0.00209	0.00449	CcSEcCtD
Terazosin—Constipation—Vincristine—muscle cancer	0.00209	0.00449	CcSEcCtD
Terazosin—Osteoarthritis—Doxorubicin—muscle cancer	0.00209	0.00449	CcSEcCtD
Terazosin—Pain in extremity—Doxorubicin—muscle cancer	0.00209	0.00449	CcSEcCtD
Terazosin—Asthma—Methotrexate—muscle cancer	0.00208	0.00448	CcSEcCtD
Terazosin—Chest pain—Etoposide—muscle cancer	0.00206	0.00443	CcSEcCtD
Terazosin—Migraine—Doxorubicin—muscle cancer	0.00205	0.00442	CcSEcCtD
Terazosin—Discomfort—Etoposide—muscle cancer	0.00204	0.00438	CcSEcCtD
Terazosin—Face oedema—Doxorubicin—muscle cancer	0.00201	0.00433	CcSEcCtD
Terazosin—Hypersensitivity—Dactinomycin—muscle cancer	0.00201	0.00433	CcSEcCtD
Terazosin—Gastrointestinal pain—Vincristine—muscle cancer	0.002	0.00429	CcSEcCtD
Terazosin—Confusional state—Etoposide—muscle cancer	0.00199	0.00429	CcSEcCtD
Terazosin—Anaphylactic shock—Etoposide—muscle cancer	0.00198	0.00425	CcSEcCtD
Terazosin—Asthenia—Dactinomycin—muscle cancer	0.00196	0.00421	CcSEcCtD
Terazosin—Dysuria—Methotrexate—muscle cancer	0.00195	0.00419	CcSEcCtD
Terazosin—Thrombocytopenia—Etoposide—muscle cancer	0.00194	0.00416	CcSEcCtD
Terazosin—Tachycardia—Etoposide—muscle cancer	0.00193	0.00415	CcSEcCtD
Terazosin—Abdominal pain—Vincristine—muscle cancer	0.00193	0.00415	CcSEcCtD
Terazosin—Body temperature increased—Vincristine—muscle cancer	0.00193	0.00415	CcSEcCtD
Terazosin—Erectile dysfunction—Methotrexate—muscle cancer	0.00192	0.00412	CcSEcCtD
Terazosin—Hyperhidrosis—Etoposide—muscle cancer	0.00191	0.00411	CcSEcCtD
Terazosin—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00191	0.0041	CcSEcCtD
Terazosin—Photosensitivity reaction—Methotrexate—muscle cancer	0.0019	0.00409	CcSEcCtD
Terazosin—Hypokalaemia—Doxorubicin—muscle cancer	0.0019	0.00408	CcSEcCtD
Terazosin—Anorexia—Etoposide—muscle cancer	0.00188	0.00405	CcSEcCtD
Terazosin—Diarrhoea—Dactinomycin—muscle cancer	0.00187	0.00402	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—muscle cancer	0.00187	0.00401	CcSEcCtD
Terazosin—Depression—Methotrexate—muscle cancer	0.00185	0.00398	CcSEcCtD
Terazosin—Hypotension—Etoposide—muscle cancer	0.00185	0.00397	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—muscle cancer	0.00185	0.00397	CcSEcCtD
Terazosin—Conjunctivitis—Methotrexate—muscle cancer	0.0018	0.00388	CcSEcCtD
Terazosin—Asthma—Doxorubicin—muscle cancer	0.0018	0.00388	CcSEcCtD
Terazosin—Influenza—Doxorubicin—muscle cancer	0.0018	0.00388	CcSEcCtD
Terazosin—Hypersensitivity—Vincristine—muscle cancer	0.0018	0.00387	CcSEcCtD
Terazosin—Sweating—Methotrexate—muscle cancer	0.00178	0.00383	CcSEcCtD
Terazosin—Paraesthesia—Etoposide—muscle cancer	0.00178	0.00382	CcSEcCtD
Terazosin—Dyspnoea—Etoposide—muscle cancer	0.00176	0.00379	CcSEcCtD
Terazosin—Somnolence—Etoposide—muscle cancer	0.00176	0.00378	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—muscle cancer	0.00176	0.00378	CcSEcCtD
Terazosin—Epistaxis—Methotrexate—muscle cancer	0.00175	0.00377	CcSEcCtD
Terazosin—Asthenia—Vincristine—muscle cancer	0.00175	0.00377	CcSEcCtD
Terazosin—Vomiting—Dactinomycin—muscle cancer	0.00174	0.00373	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—muscle cancer	0.00173	0.00373	CcSEcCtD
Terazosin—Rash—Dactinomycin—muscle cancer	0.00172	0.0037	CcSEcCtD
Terazosin—Decreased appetite—Etoposide—muscle cancer	0.00172	0.0037	CcSEcCtD
Terazosin—Fatigue—Etoposide—muscle cancer	0.0017	0.00366	CcSEcCtD
Terazosin—Pain—Etoposide—muscle cancer	0.00169	0.00364	CcSEcCtD
Terazosin—Constipation—Etoposide—muscle cancer	0.00169	0.00364	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—muscle cancer	0.00169	0.00363	CcSEcCtD
Terazosin—Diarrhoea—Vincristine—muscle cancer	0.00167	0.00359	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—muscle cancer	0.00167	0.00358	CcSEcCtD
Terazosin—Pharyngitis—Methotrexate—muscle cancer	0.00165	0.00356	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00165	0.00354	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—muscle cancer	0.00164	0.00353	CcSEcCtD
Terazosin—Feeling abnormal—Etoposide—muscle cancer	0.00163	0.0035	CcSEcCtD
Terazosin—Nausea—Dactinomycin—muscle cancer	0.00162	0.00349	CcSEcCtD
Terazosin—Gastrointestinal pain—Etoposide—muscle cancer	0.00162	0.00348	CcSEcCtD
Terazosin—Dizziness—Vincristine—muscle cancer	0.00161	0.00347	CcSEcCtD
Terazosin—Visual impairment—Methotrexate—muscle cancer	0.00161	0.00345	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—muscle cancer	0.00157	0.00337	CcSEcCtD
Terazosin—Body temperature increased—Etoposide—muscle cancer	0.00156	0.00336	CcSEcCtD
Terazosin—Abdominal pain—Etoposide—muscle cancer	0.00156	0.00336	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—muscle cancer	0.00156	0.00336	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—muscle cancer	0.00156	0.00336	CcSEcCtD
Terazosin—Eye disorder—Methotrexate—muscle cancer	0.00156	0.00335	CcSEcCtD
Terazosin—Tinnitus—Methotrexate—muscle cancer	0.00155	0.00334	CcSEcCtD
Terazosin—Vomiting—Vincristine—muscle cancer	0.00155	0.00334	CcSEcCtD
Terazosin—Sweating—Doxorubicin—muscle cancer	0.00154	0.00331	CcSEcCtD
Terazosin—Rash—Vincristine—muscle cancer	0.00154	0.00331	CcSEcCtD
Terazosin—Dermatitis—Vincristine—muscle cancer	0.00154	0.00331	CcSEcCtD
Terazosin—Headache—Vincristine—muscle cancer	0.00153	0.00329	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—muscle cancer	0.00152	0.00326	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—muscle cancer	0.00151	0.00324	CcSEcCtD
Terazosin—Hypersensitivity—Etoposide—muscle cancer	0.00146	0.00313	CcSEcCtD
Terazosin—Malnutrition—Methotrexate—muscle cancer	0.00145	0.00312	CcSEcCtD
Terazosin—Nausea—Vincristine—muscle cancer	0.00145	0.00312	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—muscle cancer	0.00145	0.00311	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—muscle cancer	0.00143	0.00308	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—muscle cancer	0.00142	0.00306	CcSEcCtD
Terazosin—Dysgeusia—Methotrexate—muscle cancer	0.00142	0.00306	CcSEcCtD
Terazosin—Asthenia—Etoposide—muscle cancer	0.00142	0.00305	CcSEcCtD
Terazosin—Back pain—Methotrexate—muscle cancer	0.0014	0.00302	CcSEcCtD
Terazosin—Pruritus—Etoposide—muscle cancer	0.0014	0.00301	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—muscle cancer	0.00139	0.00299	CcSEcCtD
Terazosin—Vision blurred—Methotrexate—muscle cancer	0.00137	0.00294	CcSEcCtD
Terazosin—Diarrhoea—Etoposide—muscle cancer	0.00135	0.00291	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—muscle cancer	0.00135	0.0029	CcSEcCtD
Terazosin—Ill-defined disorder—Methotrexate—muscle cancer	0.00135	0.00289	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—muscle cancer	0.00135	0.00289	CcSEcCtD
Terazosin—Malaise—Methotrexate—muscle cancer	0.00131	0.00281	CcSEcCtD
Terazosin—Dizziness—Etoposide—muscle cancer	0.00131	0.00281	CcSEcCtD
Terazosin—Vertigo—Methotrexate—muscle cancer	0.0013	0.0028	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—muscle cancer	0.00129	0.00277	CcSEcCtD
Terazosin—Cough—Methotrexate—muscle cancer	0.00127	0.00272	CcSEcCtD
Terazosin—Convulsion—Methotrexate—muscle cancer	0.00126	0.0027	CcSEcCtD
Terazosin—Vomiting—Etoposide—muscle cancer	0.00126	0.0027	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—muscle cancer	0.00126	0.0027	CcSEcCtD
Terazosin—Rash—Etoposide—muscle cancer	0.00125	0.00268	CcSEcCtD
Terazosin—Dermatitis—Etoposide—muscle cancer	0.00125	0.00268	CcSEcCtD
Terazosin—Headache—Etoposide—muscle cancer	0.00124	0.00266	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—muscle cancer	0.00124	0.00266	CcSEcCtD
Terazosin—Myalgia—Methotrexate—muscle cancer	0.00124	0.00266	CcSEcCtD
Terazosin—Arthralgia—Methotrexate—muscle cancer	0.00124	0.00266	CcSEcCtD
Terazosin—Chest pain—Methotrexate—muscle cancer	0.00124	0.00266	CcSEcCtD
Terazosin—Tension—Doxorubicin—muscle cancer	0.00123	0.00265	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—muscle cancer	0.00123	0.00265	CcSEcCtD
Terazosin—Discomfort—Methotrexate—muscle cancer	0.00122	0.00262	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—muscle cancer	0.00122	0.00262	CcSEcCtD
Terazosin—Back pain—Doxorubicin—muscle cancer	0.00122	0.00261	CcSEcCtD
Terazosin—Confusional state—Methotrexate—muscle cancer	0.00119	0.00257	CcSEcCtD
Terazosin—Anaphylactic shock—Methotrexate—muscle cancer	0.00118	0.00255	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—muscle cancer	0.00118	0.00255	CcSEcCtD
Terazosin—Nausea—Etoposide—muscle cancer	0.00117	0.00252	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—muscle cancer	0.00117	0.00251	CcSEcCtD
Terazosin—Thrombocytopenia—Methotrexate—muscle cancer	0.00116	0.00249	CcSEcCtD
Terazosin—Hyperhidrosis—Methotrexate—muscle cancer	0.00114	0.00246	CcSEcCtD
Terazosin—Malaise—Doxorubicin—muscle cancer	0.00113	0.00244	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—muscle cancer	0.00113	0.00243	CcSEcCtD
Terazosin—Anorexia—Methotrexate—muscle cancer	0.00113	0.00243	CcSEcCtD
Terazosin—Syncope—Doxorubicin—muscle cancer	0.00113	0.00242	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—muscle cancer	0.00111	0.00239	CcSEcCtD
Terazosin—Hypotension—Methotrexate—muscle cancer	0.00111	0.00238	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—muscle cancer	0.0011	0.00237	CcSEcCtD
Terazosin—Cough—Doxorubicin—muscle cancer	0.0011	0.00236	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—muscle cancer	0.00109	0.00234	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00108	0.00232	CcSEcCtD
Terazosin—Insomnia—Methotrexate—muscle cancer	0.00107	0.0023	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—muscle cancer	0.00107	0.0023	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—muscle cancer	0.00107	0.0023	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—muscle cancer	0.00107	0.0023	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—muscle cancer	0.00107	0.00229	CcSEcCtD
Terazosin—Paraesthesia—Methotrexate—muscle cancer	0.00106	0.00229	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—muscle cancer	0.00106	0.00227	CcSEcCtD
Terazosin—Dyspnoea—Methotrexate—muscle cancer	0.00106	0.00227	CcSEcCtD
Terazosin—Somnolence—Methotrexate—muscle cancer	0.00105	0.00226	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—muscle cancer	0.00105	0.00225	CcSEcCtD
Terazosin—Dyspepsia—Methotrexate—muscle cancer	0.00104	0.00224	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—muscle cancer	0.00103	0.00222	CcSEcCtD
Terazosin—Decreased appetite—Methotrexate—muscle cancer	0.00103	0.00221	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—muscle cancer	0.00103	0.0022	CcSEcCtD
Terazosin—Oedema—Doxorubicin—muscle cancer	0.00103	0.0022	CcSEcCtD
Terazosin—Fatigue—Methotrexate—muscle cancer	0.00102	0.0022	CcSEcCtD
Terazosin—Pain—Methotrexate—muscle cancer	0.00101	0.00218	CcSEcCtD
Terazosin—Shock—Doxorubicin—muscle cancer	0.00101	0.00217	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—muscle cancer	0.001	0.00216	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—muscle cancer	0.001	0.00215	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000991	0.00213	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—muscle cancer	0.000977	0.0021	CcSEcCtD
Terazosin—Feeling abnormal—Methotrexate—muscle cancer	0.000976	0.0021	CcSEcCtD
Terazosin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000968	0.00208	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—muscle cancer	0.000958	0.00206	CcSEcCtD
Terazosin—Body temperature increased—Methotrexate—muscle cancer	0.000936	0.00201	CcSEcCtD
Terazosin—Abdominal pain—Methotrexate—muscle cancer	0.000936	0.00201	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000934	0.00201	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—muscle cancer	0.000927	0.00199	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—muscle cancer	0.000921	0.00198	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—muscle cancer	0.000914	0.00197	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—muscle cancer	0.000912	0.00196	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—muscle cancer	0.000903	0.00194	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—muscle cancer	0.000891	0.00192	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—muscle cancer	0.000884	0.0019	CcSEcCtD
Terazosin—Pain—Doxorubicin—muscle cancer	0.000877	0.00189	CcSEcCtD
Terazosin—Constipation—Doxorubicin—muscle cancer	0.000877	0.00189	CcSEcCtD
Terazosin—Hypersensitivity—Methotrexate—muscle cancer	0.000873	0.00188	CcSEcCtD
Terazosin—Asthenia—Methotrexate—muscle cancer	0.00085	0.00183	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—muscle cancer	0.000845	0.00182	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000839	0.0018	CcSEcCtD
Terazosin—Pruritus—Methotrexate—muscle cancer	0.000838	0.0018	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—muscle cancer	0.000811	0.00174	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—muscle cancer	0.000811	0.00174	CcSEcCtD
Terazosin—Diarrhoea—Methotrexate—muscle cancer	0.00081	0.00174	CcSEcCtD
Terazosin—Dizziness—Methotrexate—muscle cancer	0.000783	0.00168	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—muscle cancer	0.000756	0.00162	CcSEcCtD
Terazosin—Vomiting—Methotrexate—muscle cancer	0.000753	0.00162	CcSEcCtD
Terazosin—Rash—Methotrexate—muscle cancer	0.000747	0.00161	CcSEcCtD
Terazosin—Dermatitis—Methotrexate—muscle cancer	0.000746	0.0016	CcSEcCtD
Terazosin—Headache—Methotrexate—muscle cancer	0.000742	0.0016	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—muscle cancer	0.000736	0.00158	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—muscle cancer	0.000725	0.00156	CcSEcCtD
Terazosin—Nausea—Methotrexate—muscle cancer	0.000703	0.00151	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—muscle cancer	0.000702	0.00151	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—muscle cancer	0.000678	0.00146	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—muscle cancer	0.000652	0.0014	CcSEcCtD
Terazosin—Rash—Doxorubicin—muscle cancer	0.000647	0.00139	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—muscle cancer	0.000646	0.00139	CcSEcCtD
Terazosin—Headache—Doxorubicin—muscle cancer	0.000642	0.00138	CcSEcCtD
Terazosin—Nausea—Doxorubicin—muscle cancer	0.000609	0.00131	CcSEcCtD
